1-16400892-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_198546.1(SPATA21):āc.1002C>Gā(p.Asn334Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,611,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N334D) has been classified as Uncertain significance.
Frequency
Consequence
NM_198546.1 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA21 | NM_198546.1 | c.1002C>G | p.Asn334Lys | missense_variant, splice_region_variant | 11/13 | ENST00000335496.5 | NP_940948.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA21 | ENST00000335496.5 | c.1002C>G | p.Asn334Lys | missense_variant, splice_region_variant | 11/13 | 1 | NM_198546.1 | ENSP00000335612.1 | ||
SPATA21 | ENST00000540400.1 | c.933C>G | p.Asn311Lys | missense_variant, splice_region_variant | 9/11 | 1 | ENSP00000440046.1 | |||
SPATA21 | ENST00000491418.5 | c.126C>G | p.Asn42Lys | missense_variant, splice_region_variant | 3/5 | 5 | ENSP00000420753.1 | |||
SPATA21 | ENST00000466212.5 | n.2294C>G | splice_region_variant, non_coding_transcript_exon_variant | 13/17 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 249834Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135112
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1459178Hom.: 0 Cov.: 33 AF XY: 0.00000551 AC XY: 4AN XY: 725902
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.1002C>G (p.N334K) alteration is located in exon 11 (coding exon 9) of the SPATA21 gene. This alteration results from a C to G substitution at nucleotide position 1002, causing the asparagine (N) at amino acid position 334 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at